References
Zhang D, Loughran TP Jr . Large granular lymphocytic leukemia: molecular pathogenesis, clinical manifestations, and treatment. Hematology Am Soc Hematol Educ Program 2012; 2012: 652–659.
Bockorny B, Dasanu CA . Autoimmune manifestations in large granular lymphocyte leukemia. Clin Lymphoma Myeloma Leuk 2012; 12: 400–405.
Firestein GS . Evolving concepts of rheumatoid arthritis. Nature 2003; 423: 356–361.
Liu X, Loughran TP Jr . The spectrum of large granular lymphocyte leukemia and Felty's syndrome. Curr Opin Hematol 2011; 18: 254–259.
Epling-Burnette PK, Liu JH, Catlett-Falcone R, Turkson J, Oshiro M, Kothapalli R et al. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Investig 2001; 107: 351–362.
Koskela HL, Eldfors S, Ellonen P, van Adrichem AJ, Kuusanmäki H, Andersson EI et al. Somatic STAT3 mutations in large granular lymphocytic leukemia. N Engl J Med 2012; 366: 1905–1913.
Watowich SS, Wu H, Socolovsky M, Klingmuller U, Constantinescu SN, Lodish HF . Cytokine receptor signal transduction and the control of hematopoietic cell development. Ann Rev Cell Dev Biol 1996; 12: 91–128.
Pesu M, Laurence A, Kishore N, Zwillich SH, Chan G, O'Shea JJ . Therapeutic targeting of Janus kinases. Immunol Rev 2008; 223: 132–142.
Fleischmann R, Kremer J, Cush J, Schulze-Koops H, Connell CA, Bradley JD et al. Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis. N Engl J Med 2012; 367: 495–507.
Traynor K . FDA approves tofacitinib for rheumatoid arthritis. Am J Health Syst Pharm 2012; 69: 2120.
Shuai K, Liu B . Regulation of JAK-STAT signaling in the immune system. Nat Rev Immunol 2003; 3: 900–911.
Lamy T, Loughran TP Jr . How I treat T-LGL leukemia. Blood 2011; 117: 2764–2774.
Mohan SR, Clemente MJ, Afable M, Cazzolli HN, Bejanyan N, Wlodarski MW et al. Therapeutic implications of variable expression of CD52 on clonal cytotoxic T cells in CD8+ large granular lymphocyte leukemia. Haematologica 2009; 94: 1407–1414.
Clemente MJ, Wlodarski MW, Makishima H, Viny AD, Bretschneider I, Shaik M et al. Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granular lymphocyte leukemia. Blood 2011; 118: 4384–4393.
Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010; 69: 1580–1588.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Bilori, B., Thota, S., Clemente, M. et al. Tofacitinib as a novel salvage therapy for refractory T-cell large granular lymphocytic leukemia. Leukemia 29, 2427–2429 (2015). https://doi.org/10.1038/leu.2015.280
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2015.280
- Springer Nature Limited
This article is cited by
-
The constitutive activation of STAT3 gene and its mutations are at the crossroad between LGL leukemia and autoimmune disorders
Blood Cancer Journal (2024)
-
Peripheral neuropathy associated with chronic lymphoproliferative disorders of natural killer cells (CLPD-NK): a case report and literature review
BMC Neurology (2023)
-
Large granular lymphocytic leukemia cured by allogeneic stem cell transplant: a case report
Journal of Medical Case Reports (2022)
-
Large Granular Lymphocytic Leukemia: Current State of Diagnosis, Pathogenesis and Treatment
Current Oncology Reports (2022)
-
Stat3 mutations impact on overall survival in large granular lymphocyte leukemia: a single-center experience of 205 patients
Leukemia (2020)